Vacara

Vacara is a Swedish private biotech focused on rheumatoid arthritis and related autoimmune diseases. The company develops novel diagnostic kits, preventive approaches, and therapeutics, with an emphasis on tolerizing vaccines, protective antibodies, and translational research tools for autoimmune arthritis. Its portfolio also includes multiplex autoantibody diagnostics such as the Joint-ID Test, monoclonal antibodies against joint and citrullinated proteins, recombinant proteins, synthetic peptides, and humanized mouse strains carrying human MHC II DRB1 alleles. The business appears to operate at a preclinical and translational stage rather than as a late-stage clinical company, while also generating revenue from research-use products and collaborative projects.